Figure 2.
Subgroup analysis of OS. (A) Subgroup with AFP ≤ 400ng/mL, the median OS (NLR-low vs NLR-high, 22.41 months vs 11.43 months, p = 0.008) was significantly better in the NLR-low group than in the NLR-high group; subgroup with AFP > 400ng/mL, the median OS (NLR-low vs NLR-high, 14.29 months vs 10.29 months, p = 0.007) was also better in the NLR-low group than in the NLR-high group. (B) Subgroup with non-macrovascular invasion, the median OS (NLR-low vs NLR-high, 25.40 months vs 12.09 months, p < 0.001) was significantly better in the NLR-low group than in the NLR-high group; subgroup with macrovascular invasion, NLR cannot be used as a predictor of OS.